Gender-specific Medicine in Cardiovascular Diseases – ISCP-endorsed Web Symposium
Online SymposiumSaturday December 5 2020: 11AM (GMT) 8:00～(Argentina), 10:00～(South Africa), 11:00～(UK), 19:00～(China), 20:00～(Japan) Registration required. Please contact with e-mail: medical@j-iscp.com for the registration. Chair Koichi Node Chief Professor, Internal Medicine and […]
Cardiovascular Prevention During COVID-19 – ISCP Webinar
Online WebinarThe International Society of Cardiovascular Pharmacotherapy (ISCP) and Asia-Pacific Heart Network (APHN) invite you to take part in an online webinar on Cardiovascular Prevention During and After the COVID-19 Pandemic. […]
European Association of Professors Emeriti: 1st Digital Educational Seminar – online
The First Digital Educational Seminar of the EAPE Committee for Prevention and Health Promotion will take place on December 1st, 18.00 CET. Free attendance - Certification Webinar link: https://zoom.us/j/99749560370?pwd=QktkemtuSlpiQzVyd1lySDcwZzljdz09 Confirmation […]
CMIS Taskforce: 2nd Chronic Myocardial Ischemic Syndrome Virtual Webinar
Join our Co-Chairs Professor Mario Marzilli (Italy) and Professor William Boden (USA) and the CMIS Task Force in the second of our two-part webinar series on chronic myocardial ischemic syndrome. […]
ACC 22 – Washington, DC
The American College of Cardiology will host the 71st Annual Scientific Session & Expo in Washington, DC, April 2 – 4, 2022. ACC.22 is your time to network with colleagues, […]
Ferric Carboxymaltose for Heart Failure – ISCP Online Webinar Series
Online WebinarFerric Carboxymaltose: Ironing Out the Issues Around Heart Failure Related Readmissions Part of the A-Z of CV Pharmacotherapy Webinar Series from the ISCP. 13th April 2022 | 11:00 BST | […]
Edoxaban: ENGAGEing in Individualisation of DOACs – ISCP Webinar
Online WebinarDirect oral anticoagulants (DOACs) have revolutionised the treatment of venous thromboembolism and atrial fibrillation. By the time edoxaban was approved in 2015, healthcare providers already had a few years of […]
Valsartan Sacubitril: Has our PARADIGM shifted?
Online webinarPatients with heart failure with preserved ejection fraction (HFpEF) suffer from poor survival, high hospitalisations rate and long-term mortality. HFpEF patients are often overlooked as compared to the more well-known HFrEF where the famous “fantastic four” are now well-known as disease-modifying therapies. The plethora […]
Novel Pharmacological Treatments for the Prevention of Cardiovascular Events
Online WebinarNovel Pharmacological Treatments for the Prevention of Cardiovascular Events Which agents to use and which patients benefit from the newer interventions? OVERVIEW This webinar focuses on the use of novel […]
Clopidogrel or Ticagrelor: Why, When, for Whom?
Online WebinarDual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor, is the cornerstone of the management of acute coronary syndromes. Despite its proven benefits, the choice of P2Y12 inhibitors […]